These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 26547373)

  • 21. Anti-biofilm potential of a glycolipid surfactant produced by a tropical marine strain of Serratia marcescens.
    Dusane DH; Pawar VS; Nancharaiah YV; Venugopalan VP; Kumar AR; Zinjarde SS
    Biofouling; 2011; 27(6):645-54. PubMed ID: 21707248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
    Zerbini E; Andreu D; Tonarelli G; Sequeira MD
    Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of N-acetylglucosamine-1-phosphate transferase (WecA) enhanced the sensitivity of Mycobacterium smegmatis against rifampin.
    Xu L; Qian L; Kang J; Sha S; Xin Y; Lu S; Ma Y
    J Appl Microbiol; 2016 Oct; 121(4):966-72. PubMed ID: 27420559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conserved structure and function in the granulysin and NK-lysin peptide family.
    Linde CM; Grundström S; Nordling E; Refai E; Brennan PJ; Andersson M
    Infect Immun; 2005 Oct; 73(10):6332-9. PubMed ID: 16177304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin.
    Khara JS; Wang Y; Ke XY; Liu S; Newton SM; Langford PR; Yang YY; Ee PL
    Biomaterials; 2014 Feb; 35(6):2032-8. PubMed ID: 24314557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane-active antimicrobial peptides and human placental lysosomal extracts are highly active against mycobacteria.
    Jena P; Mishra B; Leippe M; Hasilik A; Griffiths G; Sonawane A
    Peptides; 2011 May; 32(5):881-7. PubMed ID: 21396418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure and functional implications of LprF from Mycobacterium tuberculosis and M. bovis.
    Kim JS; Jiao L; Oh JI; Ha NC; Kim YH
    Acta Crystallogr D Biol Crystallogr; 2014 Oct; 70(Pt 10):2619-30. PubMed ID: 25286846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antimycobacterial activity of calpinactam derivatives.
    Nagai K; Koyama N; Sato N; Yanagisawa C; Tomoda H
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7739-41. PubMed ID: 23116887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and activity relationships of the anti-Mycobacterium antibiotics resorcinomycin and pheganomycin.
    Ogasawara Y; Ooya K; Fujimori M; Noike M; Dairi T
    J Antibiot (Tokyo); 2016 Feb; 69(2):119-20. PubMed ID: 26306817
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibacterial activity of long-chain fatty alcohols against mycobacteria.
    Mukherjee K; Tribedi P; Mukhopadhyay B; Sil AK
    FEMS Microbiol Lett; 2013 Jan; 338(2):177-83. PubMed ID: 23136919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition.
    Li H; Cowie A; Johnson JA; Webster D; Martyniuk CJ; Gray CA
    BMC Genomics; 2016 Aug; 17(1):621. PubMed ID: 27514659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging role of Raoultella ornithinolytica in human infections: a series of cases and review of the literature.
    Seng P; Boushab BM; Romain F; Gouriet F; Bruder N; Martin C; Paganelli F; Bernit E; Le Treut YP; Thomas P; Papazian L; Raoult D; Stein A
    Int J Infect Dis; 2016 Apr; 45():65-71. PubMed ID: 26921549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of the genes involved in glycosylation pathways of mycobacterial glycopeptidolipid biosynthesis.
    Miyamoto Y; Mukai T; Nakata N; Maeda Y; Kai M; Naka T; Yano I; Makino M
    J Bacteriol; 2006 Jan; 188(1):86-95. PubMed ID: 16352824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, in vitro anticancer and antimycobacterial evaluation of new 5-(2,5-dimethoxyphenyl)-1,3,4-thiadiazole-2-amino derivatives.
    Polkam N; Rayam P; Anireddy JS; Yennam S; Anantaraju HS; Dharmarajan S; Perumal Y; Kotapalli SS; Ummanni R; Balasubramanian S
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1398-402. PubMed ID: 25765907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Establishment and drug susceptibility test of isoniazid resistant Mycobacterium smegmatis].
    Jia PP; Zhao LL; Li XY; Zhang Q; Liu ZL; Wang X; Yu LY; Zhao LX; Cen S
    Yao Xue Xue Bao; 2011 Apr; 46(4):377-82. PubMed ID: 21751489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DFT-based QSAR models to predict the antimycobacterial activity of chalcones.
    Barua N; Sarmah P; Hussain I; Deka RC; Buragohain AK
    Chem Biol Drug Des; 2012 Apr; 79(4):553-9. PubMed ID: 22151277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioactive compound from Pseudomonas synxantha inhibits the growth of Mycobacteria.
    Mukherjee K; Mandal S; Mukhopadhyay B; Mandal NC; Sil AK
    Microbiol Res; 2014; 169(9-10):794-802. PubMed ID: 24439826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of antimycobacterial activity of a sulphonamide derivative.
    Agertt VA; Marques LL; Bonez PC; Dalmolin TV; Manzoni de Oliveira GN; de Campos MM
    Tuberculosis (Edinb); 2013 May; 93(3):318-21. PubMed ID: 23474303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic arabinomannan glycolipids impede mycobacterial growth, sliding motility and biofilm structure.
    Syal K; Maiti K; Naresh K; Avaji PG; Chatterji D; Jayaraman N
    Glycoconj J; 2016 Oct; 33(5):763-77. PubMed ID: 27263096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria.
    Carroll J; Draper LA; O'Connor PM; Coffey A; Hill C; Ross RP; Cotter PD; O'Mahony J
    Int J Antimicrob Agents; 2010 Aug; 36(2):132-6. PubMed ID: 20547041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.